Comparison of vitrectomy outcomes for eyes with proliferative vitreoretinopathy with various silicon oil.

Comparison of vitrectomy outcomes for eyes with proliferative vitreoretinopathy with various silicon oil. - Comparison of vitrectomy outcomes with various silicon oil

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011739

Enrollment

100

Registered

2013-09-12

Start date

2012-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

proliferative vitreoretinopathy

Interventions

SIL-5000 Siluron2000 Siluron5000 Densiron68 Oxane HD

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patient who will perform proliferative vitreous surgery

Exclusion criteria

Exclusion criteria: 1)This agent ingredient hypersensitivity 2)The patient who this research responsibility (assignment) doctor accepted was unsuitable as a subject 3)The patient who has other ocular complications or systemic complications was unsuitable for silicon oil injection.

Design outcomes

Primary

Measure	Time frame
visual acuity intraocular pressure fundus examination	—

Countries

Japan

Contacts

Public ContactKazuhiro Kimura

Yamaguchi University Graduate School of Medicine Ophthalmology

k.kimura@yamaguchi-u.ac.jp+81-836-222278

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026